Vice President of Supply Chain for Emerging Markets - GSK’s Pharmaceutical Business
Mark Dawson is Vice President of Supply Chain for Emerging Markets within GSK’s Pharmaceutical Business. Mark joined GSK in 2005 working in various roles of increasing seniority within Global Manufacturing and Supply as Engineering Director, Site Director for the Irvine manufacturing site and most recently was VP and Head of Global Supply Chain within ViiV Healthcare, GSK’s HIV business. Mark has held various private and public Board positions including ViiV Healthcare, the University of Sheffield and the Irvine Bay Regeneration Company.
Prior to GSK, Mark worked for several multinational companies including Eli Lilly & Company, Kvaerner and Schneider Electric. Mark is a graduate of the University of Sheffield in the UK and a Chartered Engineer.